PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5416.79M
Enterprise Value 3323.71M
Trailing P/E N/A
Forward P/E 1-41.08
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)26.68
Price/Book (mrq)4.12
Enterprise Value/Revenue 320.72
Enterprise Value/EBITDA 6-6.82

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-313.38%

Management Effectiveness

Return on Assets (ttm)-19.40%
Return on Equity (ttm)-82.24%

Income Statement

Revenue (ttm)15.62M
Revenue Per Share (ttm)0.20
Quarterly Revenue Growth (yoy)-16.70%
Gross Profit (ttm)N/A
EBITDA -47.46M
Net Income Avi to Common (ttm)-67.66M
Diluted EPS (ttm)-0.8700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.69M
Total Cash Per Share (mrq)1.63
Total Debt (mrq)44.6M
Total Debt/Equity (mrq)44.12
Current Ratio (mrq)6.15
Book Value Per Share (mrq)1.20

Cash Flow Statement

Operating Cash Flow (ttm)-46.75M
Levered Free Cash Flow (ttm)-22.94M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.05
52-Week Change 3-27.16%
S&P500 52-Week Change 311.15%
52 Week High 39.4200
52 Week Low 33.6200
50-Day Moving Average 34.6609
200-Day Moving Average 34.7904

Share Statistics

Avg Vol (3 month) 31.27M
Avg Vol (10 day) 3819.95k
Shares Outstanding 584.54M
Float 72.37M
% Held by Insiders 16.46%
% Held by Institutions 186.34%
Shares Short (Mar 29, 2019) 410.13M
Short Ratio (Mar 29, 2019) 46.05
Short % of Float (Mar 29, 2019) 419.35%
Short % of Shares Outstanding (Mar 29, 2019) 411.98%
Shares Short (prior month Feb 28, 2019) 49.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A